High sustained virologic response rates, regardless of race or socioeconomic class, in patients treated with chronic hepatitis C in community practice using a specialized pharmacy team

Approved direct-acting antiviral (DAA) regimens against hepatitis C virus (HCV) can cure nearly all patients; however, socioeconomic disparities may impact access and outcome. This study assesses socioeconomic factors, differences in insurance coverage and the drug prior authorization process in HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwelker, Saatchi, Tsai, Eugenia, Kuo, Lily, Kim, Jae, Van Frank, Timothy, Mitchell, Robert, Ramirez, Ruben, Guerrero, Richard, Hanysak, Bryan, Landaverde, Carmen, Rodas, Fabian, Lawitz, Eric, Basra, Tamneet, Nguyen, Harry, Christensen, Kim, Vaughn, Clarissa, Hinojosa, Kim, Olvera, Nina, Caraballo-Gonzalez, Edna, Pham, Emma, Pedicone, Lisa D., Poordad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article: Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378881/
https://www.ncbi.nlm.nih.gov/pubmed/37505173
http://dx.doi.org/10.1097/MD.0000000000034183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378881/
https://www.ncbi.nlm.nih.gov/pubmed/37505173
http://dx.doi.org/10.1097/MD.0000000000034183

Ejemplares similares